Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2026-06-01 18:00:13 ET · period of report 2026-05-29 · accession 0001365619-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-01 18:00 | 2026-05-29 | ACAD | Brege Laura | Dir | M - OptEx | — | +8,107 | 23.2K | +54% | — |
| D | 2026-06-01 18:00 | 2026-05-29 | ACAD | Brege Laura | Dir | M - OptEx | $0.00 | -8,107 | 0 | -100% | $0 |
| DM | 2026-06-01 18:00 | 2026-05-29 | ACAD | Brege Laura | Dir | A - Grant | $0.00 | +25.3K | 9,311 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | M | A | 8,107 | — | 23,202 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. |
| 2 | Derivative | Restricted Stock Units | 2026-05-29 | M | D | 8,107 | $0.00 | 0 | D | — · — to — | 8,107 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. (F2) The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held. (F2) The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held. |
| 3 | Derivative | Director Stock Options (Right to Buy) | 2026-05-29 | A | A | 16,004 | $0.00 | 16,004 | D | $21.66 · — to 2036-05-28 | 16,004 Common Stock | (F3) The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders. |
| 4 | Derivative | Restricted Stock Units | 2026-05-29 | A | A | 9,311 | $0.00 | 9,311 | D | — · — to — | 9,311 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. (F4) The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended. (F4) The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended. |